Therapy News and Research

RSS

JVIR supplement to review thermal ablation usage in treating cancer

The unprecedented growth and promise of using thermal ablation to target and kill cancer is the subject of the Journal of Vascular and Interventional Radiology's August supplement, "Thermal Ablation 2010 At the Crossroads of Past Success, Current Goals and Future Technology."

27 Aug 2010

Researchers recommend traumatic brain injury reclassification for additional funding

Traumatic brain injury, currently considered a singular event by the insurance industry and many health care providers, is instead the beginning of an ongoing process that impacts multiple organ systems and may cause or accelerate other diseases and disorders that can reduce life expectancy, according to research from the University of Texas Medical Branch at Galveston.

27 Aug 2010

Nationwide Children's Hospital designated as Wellstone Muscular Dystrophy Cooperative Research Center

A $7 million grant from the National Institutes of Health (NIH) will help researchers at Nationwide Children's Hospital translate new scientific findings and technological developments into novel treatments for the muscular dystrophies. The grant designates Nationwide Children's Hospital as a Paul D. Wellstone Muscular Dystrophy Cooperative Research Center, one of three national award recipients in 2010.

27 Aug 2010

Bioheart reports promising result for congestive heart failure treatment with stem cell therapy

Bioheart, Inc., announces that the treatments and 3 month follow up with stem cell therapy on the first two congestive heart failure patients has been performed successfully at Hospital Angeles Tijuana through its Center of Excellence, Regenerative Medicine Institute of Tijuana, Mexico.

27 Aug 2010

Ants use antibiotics to inhibit growth of unwanted fungi, bacteria

Research led by Dr Matt Hutchings and published today in the journal BMC Biology shows that ants use the antibiotics to inhibit the growth of unwanted fungi and bacteria in their fungus cultures which they use to feed their larvae and queen.

27 Aug 2010

Battery of tests for quick assessment of cognitive abilities in Down syndrome patients

Neuroscientists in the Down Syndrome Research Group at the University of Arizona have created a battery of tests that quickly aid in the assessment of the cognitive abilities of persons with Down syndrome.

27 Aug 2010

AgeneBio receives grant to develop neural stabilizer therapy for amnestic mild cognitive impairment

The Alzheimer's Drug Discovery Foundation (ADDF) announced today that it has awarded a grant of $240,000 to AgeneBio Inc. to develop a new class of small-molecules that have promise in treating amnestic mild cognitive impairment (aMCI), a neurological condition that often progresses to Alzheimer's disease and affects more than 3 million aging Americans.

27 Aug 2010

New vibration technology to reduce stubborn stomach fat

For millions of dieters it seems impossible to lose belly fat no matter however carefully they watch what they eat or how many sit-ups they do. Some people give up and blame it on genetics, metabolism or body type and simply accept it as a fact of life. For whatever the reason, many Americans discover that stubborn fat around the stomach and love handles will not melt away despite their best efforts. Now a fitness research company says there is an effective way to win the battle of the bulge without special diets, drinks or difficult exercises.

27 Aug 2010

Veterans Affairs partners with NIH to grant award for substance abuse research in military personnel

The Department of Veterans Affairs is partnering with the National Institutes of Health (NIH) to award $6 million in grants for research examining the link between substance abuse and military deployments and combat-related trauma.

26 Aug 2010

China PharmaHub signs distribution agreement for radioactive glass sphere treatment for liver cancer

China PharmaHub Corp. ("PharmaHub"), which has recently merged with World Wide Relics which has changed its name to China PharmaHub Corp, and is in the process of obtaining approval from FINRA to trade under its new name with a new symbol, announced today that it has signed an Exclusive Distribution Agreement ("Agreement") with a world leader in precision glass technology which can be utilized to manufacture high precision radioactive glass spheres that emit alpha, beta or gamma radiation, either individually or in combination, for the treatment of malignant tumors of the liver.

26 Aug 2010

Aethlon Medical receives approval for Chronic HCV Infection treatment

Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that the Medanta Independent Ethics Committee (MIEC) at Medanta, The Medicity Institute (Medicity) has approved a treatment program entitled "Use of the Aethlon Hemopurifier in Treating Chronic HCV Infection in Combination with Standard of Care (SOC) Drug Therapy."

26 Aug 2010

American HomePatient announces extension of self-tender offer

American HomePatient, Inc., one of the nation's largest home health care providers, today announced that it is extending its previously announced self-tender offer for all outstanding shares of common stock of the Company at $0.67 per share, until 5:00 P.M., New York City time, Wednesday, September 1, 2010, unless the tender offer is further extended.

26 Aug 2010

Medtronic Ablation Frontiers Cardiac Ablation System receives Health Canada approval

Medtronic, Inc. today announced it received Health Canada approval for the Medtronic Ablation Frontiers Cardiac Ablation System, a novel radiofrequency ablation technology for the treatment of atrial fibrillation. AF is the most common heart arrhythmia that affects more than 250,000 Canadians and seven million people worldwide.

26 Aug 2010

Dose-defining Phase IIa trial of CXL-1020 initiated for treating patients with ADHF

Cardioxyl Pharmaceuticals, Inc., a clinical-stage pharmaceutical company developing therapeutic agents for the treatment of cardiovascular disease, today announced that it has initiated a dose-defining Phase IIa trial of its lead drug candidate, CXL-1020, for the treatment of patients with acute decompensated heart failure.

26 Aug 2010

Restat announces signing of PEBA as latest Align cost-plus pricing model client

Restat, the nation's largest independent pharmacy benefits manager has announced the signing of the Public Employee Benefits Alliance as its latest Align cost-plus pricing model client. PEBA, an organization formed by several Texas government employers, cooperatively purchases employee benefits -- including health care benefits -- on behalf of the local government entities.

26 Aug 2010

23rd European College of Neuropsychopharmacology Congress to be held 28 Aug - 1 Sep 2010 in Amsterdam

Mental disorders, such as depression, anxiety disorders, addiction and schizophrenia are the core challenge of most health care systems around the world. In the EU alone, each year 27% of the total adult population - this corresponds to 83 Million citizens - suffer from mental disorders. Depression alone affects almost 20 million ranking in the EU as the most disabling disorder of all diseases.

26 Aug 2010

YFALS Campaign to appear in Milwaukee, Atlanta and Seattle

The Young Faces of ALS Campaign raises awareness of ALS and those diagnosed with the progressive neurodegenerative disease at a young age. Starting today, the campaign will make stops at Major League Baseball ballparks in Milwaukee, Atlanta and Seattle.

26 Aug 2010

SNM supports U.S. Senate's introduction of CARE Act

SNM supports the U.S. Senate in its introduction of the Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2010, S. 3737. The proposed legislation, which was introduced in August by Sen. Mike Enzi [R-WY], aims to ensure that minimum education and credentialing standards for nuclear medicine technologists are set at the state level.

26 Aug 2010

Saint Thomas Health Services to offer program for neurosurgical patients’ better care

August is Neurosurgery Outreach Month, an effort to increase the public's knowledge about the powerful effects of neurosurgery, many of which are taking place at Saint Thomas Health Services in Tennessee.

26 Aug 2010

PLX4032 therapy results in tumor shrinkage in metastatic melanoma patients

A multicenter study has concluded that treatment with a new targeted therapy called PLX4032 (also called RG7204) resulted in significant tumor shrinkage in 80 percent of patients with advanced melanoma.

26 Aug 2010

Therapy News and Research

JVIR supplement to review thermal ablation usage in treating cancer

Researchers recommend traumatic brain injury reclassification for additional funding

Nationwide Children's Hospital designated as Wellstone Muscular Dystrophy Cooperative Research Center

Bioheart reports promising result for congestive heart failure treatment with stem cell therapy

Ants use antibiotics to inhibit growth of unwanted fungi, bacteria

Battery of tests for quick assessment of cognitive abilities in Down syndrome patients

AgeneBio receives grant to develop neural stabilizer therapy for amnestic mild cognitive impairment

New vibration technology to reduce stubborn stomach fat

Veterans Affairs partners with NIH to grant award for substance abuse research in military personnel

China PharmaHub signs distribution agreement for radioactive glass sphere treatment for liver cancer

Aethlon Medical receives approval for Chronic HCV Infection treatment

American HomePatient announces extension of self-tender offer

Medtronic Ablation Frontiers Cardiac Ablation System receives Health Canada approval

Dose-defining Phase IIa trial of CXL-1020 initiated for treating patients with ADHF

Restat announces signing of PEBA as latest Align cost-plus pricing model client

23rd European College of Neuropsychopharmacology Congress to be held 28 Aug - 1 Sep 2010 in Amsterdam

YFALS Campaign to appear in Milwaukee, Atlanta and Seattle

SNM supports U.S. Senate's introduction of CARE Act

Saint Thomas Health Services to offer program for neurosurgical patients’ better care

PLX4032 therapy results in tumor shrinkage in metastatic melanoma patients

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News